Teladoc Health Reports Third Quarter 2019 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Teladoc (TDOC) Tops Q3 EPS by 12c, Revenues Beat; Updates FY19 EPS/Revenue Guidance Above Consensus, Affirms Q4 EPS/Revenue Views
October 30, 2019 5:07 PM EDTTeladoc (NYSE: TDOC) reported Q3 EPS of ($0.28), $0.12 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $138 million versus the consensus estimate of $136.47 million.
Year-over-year Q3 revenue grows 24% to $138.0 million and total visits increase 45% to 928,000Year-over-year nine months revenue grows 34% to $396.8 million and total visits increase 63% to 2,899,000Issues 2019 fourth-quarter guidance and updates full-year expectationsThe third quarter marked a continuation of Teladoc Healths very strong momentum from the first half of the year, as we... More
